Clinical Trials Related to Merck Sharp & Dohme LLC

Related studies linked through entity extraction aliases.

A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)

Status: COMPLETED
Phase: PHASE1

Testosterone and Alendronate in Hypogonadal Men

Status: TERMINATED
Phase: PHASE2

Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)

Status: UNKNOWN
Phase: PHASE3

Impact of Adherence to Treatment in Asthma Control

Status: COMPLETED
Phase: N/A

Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects

Status: COMPLETED
Phase: N/A

RAltegravir Switch STudy: Effects on Endothelial Recovery

Status: UNKNOWN
Phase: PHASE4

Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)

Status: COMPLETED
Phase: PHASE3

Renal Transplantation and Raltegravir in HIV-Infected Patients

Status: COMPLETED
Phase: PHASE3

Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide

Status: TERMINATED
Phase: N/A

A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155)

Status: COMPLETED
Phase: PHASE1

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649)

Status: TERMINATED
Phase: PHASE1

Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide

Status: COMPLETED
Phase: PHASE2

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

Status: COMPLETED
Phase: PHASE4

A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV

Status: TERMINATED
Phase: PHASE4

Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers

Status: UNKNOWN
Phase: PHASE4

A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years

Status: COMPLETED
Phase: N/A

A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)

Status: COMPLETED
Phase: PHASE1

Study of Dual Trigger Ovulation in Oocyte Donors

Status: TERMINATED
Phase: PHASE4

Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)

Status: TERMINATED
Phase: PHASE2

Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy

Status: COMPLETED
Phase: N/A